NL191777C - Gelyofiliseerd farmaceutisch preparaat met anti-bacteriële werking. - Google Patents

Gelyofiliseerd farmaceutisch preparaat met anti-bacteriële werking.

Info

Publication number
NL191777C
NL191777C NL8102943A NL8102943A NL191777C NL 191777 C NL191777 C NL 191777C NL 8102943 A NL8102943 A NL 8102943A NL 8102943 A NL8102943 A NL 8102943A NL 191777 C NL191777 C NL 191777C
Authority
NL
Netherlands
Prior art keywords
pharmaceutical preparation
antibacterial action
lyophilized pharmaceutical
lyophilized
antibacterial
Prior art date
Application number
NL8102943A
Other languages
English (en)
Other versions
NL8102943A (nl
NL191777B (nl
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of NL8102943A publication Critical patent/NL8102943A/nl
Publication of NL191777B publication Critical patent/NL191777B/nl
Application granted granted Critical
Publication of NL191777C publication Critical patent/NL191777C/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NL8102943A 1980-06-23 1981-06-18 Gelyofiliseerd farmaceutisch preparaat met anti-bacteriële werking. NL191777C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8578980A JPS5711909A (en) 1980-06-23 1980-06-23 Stable freeze-dried preparation of beta-lactam
JP8578980 1980-06-23

Publications (3)

Publication Number Publication Date
NL8102943A NL8102943A (nl) 1982-01-18
NL191777B NL191777B (nl) 1996-04-01
NL191777C true NL191777C (nl) 1996-08-02

Family

ID=13868648

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8102943A NL191777C (nl) 1980-06-23 1981-06-18 Gelyofiliseerd farmaceutisch preparaat met anti-bacteriële werking.

Country Status (31)

Country Link
US (1) US4418058A (nl)
JP (1) JPS5711909A (nl)
KR (1) KR840000693B1 (nl)
AR (1) AR230007A1 (nl)
AT (1) AT380790B (nl)
AU (1) AU541627B2 (nl)
BE (1) BE889351A (nl)
BG (1) BG37991A3 (nl)
CA (1) CA1164801A (nl)
CH (1) CH648210A5 (nl)
CS (1) CS221835B2 (nl)
DD (1) DD159879A5 (nl)
DE (1) DE3124592A1 (nl)
DK (1) DK158443C (nl)
ES (1) ES8203887A1 (nl)
FI (1) FI75490C (nl)
FR (1) FR2484835A1 (nl)
GB (1) GB2078737B (nl)
GR (1) GR75646B (nl)
HU (1) HU183494B (nl)
IE (1) IE51331B1 (nl)
IL (1) IL63136A (nl)
IT (1) IT1144812B (nl)
NL (1) NL191777C (nl)
NO (1) NO156036C (nl)
NZ (1) NZ197414A (nl)
PT (1) PT73239B (nl)
RO (1) RO82720B (nl)
SE (1) SE460702B (nl)
YU (1) YU44416B (nl)
ZA (1) ZA814203B (nl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597193A (ja) * 1982-07-02 1984-01-14 Shionogi & Co Ltd マロニルメチル基の異性化方法
JPS6045514A (ja) * 1983-08-22 1985-03-12 Shionogi & Co Ltd 安定な抗菌性凍結乾燥製剤
US4797388A (en) * 1984-05-21 1989-01-10 Cetus Corporation Pharmaceutical compositions with galactitol as carrier
US4891391A (en) * 1985-01-03 1990-01-02 Morton Thiokol, Inc. Compositions containing antimicrobial agents in combination with stabilizers
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones
DE3801179A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierung von cephalosporinderivaten durch trocknung mit einem stabilisator sowie stabile zubereitungsformen mit cephalosporinderivaten
US6815435B2 (en) * 2000-07-13 2004-11-09 Daiichi Pharmaceutical Co., Ltd. Pharmaceutical compositions containing DDS compounds
US7378408B2 (en) * 2001-11-30 2008-05-27 Pfizer Inc. Methods of treatment and formulations of cephalosporin
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274993A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane-tazobactam pharmaceutical compositions
EP3100732A1 (en) 2013-03-15 2016-12-07 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS532931B2 (nl) * 1973-12-05 1978-02-01
US3928592A (en) * 1974-02-22 1975-12-23 Lilly Co Eli Antibiotic pharmaceutical compositions
US3993753A (en) * 1974-08-26 1976-11-23 American Home Products Corporation Anhydrous ampicillin stabilization and resultant compositions
GB1463563A (en) * 1974-10-10 1977-02-02 Beecham Group Ltd Pharmaceutical compositions
JPS5151511A (en) * 1974-10-25 1976-05-07 Tooru Tatsuhara Aminosanseizai no anteikaho
US4180571A (en) * 1976-03-25 1979-12-25 Shionogi & Co., Ltd. Arylmalonamido-1-oxadethiacephalosporins
JPS532931A (en) * 1976-06-30 1978-01-12 Saraya Kk Toilet bowl cleaning method
PT67409B (en) * 1976-12-17 1979-05-22 Scherico Ltd A process for rendering a beta-lactam antibiotic suitable for use in preparing an injectable antibiotic mixture
JPS53104722A (en) * 1977-02-19 1978-09-12 Tsumura Juntendo Kk Production of powder for making herb medicine liquid agent
CA1127450A (en) * 1978-08-26 1982-07-13 Gordon L. Mcglennon Load multiplying mechanisms
US4259485A (en) * 1979-04-24 1981-03-31 Eli Lilly And Company Crystallization process

Also Published As

Publication number Publication date
IT8167863A0 (it) 1981-06-22
KR840000693B1 (ko) 1984-05-21
DD159879A5 (de) 1983-04-13
NL8102943A (nl) 1982-01-18
CH648210A5 (de) 1985-03-15
IL63136A (en) 1984-07-31
JPS6364405B2 (nl) 1988-12-12
FI75490C (fi) 1988-07-11
KR830005848A (ko) 1983-09-14
JPS5711909A (en) 1982-01-21
CA1164801A (en) 1984-04-03
RO82720A (ro) 1984-05-23
PT73239B (en) 1982-07-22
GB2078737A (en) 1982-01-13
IT1144812B (it) 1986-10-29
YU44416B (en) 1990-08-31
NL191777B (nl) 1996-04-01
AR230007A1 (es) 1984-02-29
IE811347L (en) 1981-12-23
ZA814203B (en) 1982-09-29
GR75646B (nl) 1984-08-02
CS221835B2 (en) 1983-04-29
IL63136A0 (en) 1981-09-13
HU183494B (en) 1984-05-28
ES503283A0 (es) 1982-04-01
YU157381A (en) 1984-10-31
NO156036C (no) 1987-07-15
DK158443B (da) 1990-05-21
SE8103904L (sv) 1981-12-24
AU541627B2 (en) 1985-01-17
FI811948L (fi) 1981-12-24
DK274981A (da) 1981-12-24
DK158443C (da) 1990-10-08
ES8203887A1 (es) 1982-04-01
FR2484835B1 (nl) 1983-07-01
ATA278881A (de) 1985-12-15
GB2078737B (en) 1984-03-14
FI75490B (fi) 1988-03-31
AU7209781A (en) 1983-01-06
NO812090L (no) 1981-12-28
DE3124592A1 (de) 1982-02-11
FR2484835A1 (fr) 1981-12-24
BE889351A (fr) 1981-10-16
NZ197414A (en) 1984-10-19
SE460702B (sv) 1989-11-13
AT380790B (de) 1986-07-10
NO156036B (no) 1987-04-06
PT73239A (en) 1981-07-01
IE51331B1 (en) 1986-12-10
RO82720B (ro) 1984-07-30
US4418058A (en) 1983-11-29
DE3124592C2 (nl) 1990-12-20
BG37991A3 (en) 1985-09-16

Similar Documents

Publication Publication Date Title
NL187022C (nl) Rifamycine derivaten met anti-bacteriele werking, en dergelijke derivaten bevattend farmaceutisch preparaat.
DE3774264D1 (de) Pseudoephedrin-dosierungsform.
IT8222771A0 (it) Siringa.
ES264931Y (es) Jeringuilla.
IT8219339A0 (it) Cromani sostituiti ad azione farmaceutica.
NL185622C (nl) Farmaceutisch preparaat met antibacteriele werking, alsmede 7beta-acylamino-7alfa-methoxy-3-heterocyclylthiomethyl-3-cefem-4-carbonzuur.
IT8223566A0 (it) Antibiotici diossi-imminocefalosporinici.
NL191777C (nl) Gelyofiliseerd farmaceutisch preparaat met anti-bacteriële werking.
FI834732A (fi) Laoskonstruktion foer cylinderhuvud.
ES266072Y (es) Juego de construccion.
NL192740B (nl) Oxadethiacefalosporinederivaat met antibacteriële werking, alsmede bereidingswijze daarvoor en antibacteriaal preparaat daaruit.
NL185923C (nl) Farmaceutisch preparaat met antibacteriele werking, alsmede penam-3-carbonzuur-1,1-dioxyde-derivaat.
NL192926B (nl) Cefalosporinederivaat met antibacteriële werking, en farmaceutisch preparaat daaruit.
NL192111B (nl) Geneesmiddelpreparaat met anti-inflammatoire werking.
NL191744C (nl) Farmaceutisch preparaat met werking tegen epitheelletsels.
NL7806163A (nl) Farmaceutisch preparaat met anti-bacteriele werking.
NO811003L (no) Farmasoeytiske preparater.
IT1206323B (it) Preparazioni farmaceutiche con azione citostatica.
NL193821B (nl) Farmaceutisch preparaat.
NL191171C (nl) Tablet met aritmie-bestrijdende werking.
IT8219906A0 (it) 1,2,3,4-tetraidronaftaleni sostituiti con amminoalchili ad azione farmaceutica.
NL176076B (nl) Farmaceutisch preparaat met antibacteriele werking, alsmede met een acylaminogroep gesubstitueerd oleandomycinederivaat.
IT1232598B (it) Gioco logico spaziale.
FI870267A0 (fi) Stol.
IT8224294A0 (it) Perfezionamenti apportati ai trasportatori.

Legal Events

Date Code Title Description
A1A A request for search or an international-type search has been filed
BB A search report has been drawn up
A85 Still pending on 85-01-01
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 20010618